186 related articles for article (PubMed ID: 37749707)
21. The critical role of the hippocampal NLRP3 inflammasome in social isolation-induced cognitive impairment in male mice.
Niu L; Luo SS; Xu Y; Wang Z; Luo D; Yang H; Li W; He J; Zhong XL; Liu ZH; Zeng JY; Cao WY; Wan W
Neurobiol Learn Mem; 2020 Nov; 175():107301. PubMed ID: 32882398
[TBL] [Abstract][Full Text] [Related]
22. Blockage of NLRP3 inflammasome activation ameliorates acute inflammatory injury and long-term cognitive impairment induced by necrotizing enterocolitis in mice.
Zhu F; Wang L; Gong Z; Wang Y; Gao Y; Cai W; Wu J
J Neuroinflammation; 2021 Mar; 18(1):66. PubMed ID: 33676524
[TBL] [Abstract][Full Text] [Related]
23. Pharmacological Inhibition of the Nod-Like Receptor Family Pyrin Domain Containing 3 Inflammasome with MCC950.
Corcoran SE; Halai R; Cooper MA
Pharmacol Rev; 2021 Jul; 73(3):968-1000. PubMed ID: 34117094
[TBL] [Abstract][Full Text] [Related]
24. NLRP3 Inflammasome Inhibition by MCC950 Reduces Atherosclerotic Lesion Development in Apolipoprotein E-Deficient Mice-Brief Report.
van der Heijden T; Kritikou E; Venema W; van Duijn J; van Santbrink PJ; Slütter B; Foks AC; Bot I; Kuiper J
Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1457-1461. PubMed ID: 28596375
[TBL] [Abstract][Full Text] [Related]
25. MCC950/CRID3 potently targets the NACHT domain of wild-type NLRP3 but not disease-associated mutants for inflammasome inhibition.
Vande Walle L; Stowe IB; Šácha P; Lee BL; Demon D; Fossoul A; Van Hauwermeiren F; Saavedra PHV; Šimon P; Šubrt V; Kostka L; Stivala CE; Pham VC; Staben ST; Yamazoe S; Konvalinka J; Kayagaki N; Lamkanfi M
PLoS Biol; 2019 Sep; 17(9):e3000354. PubMed ID: 31525186
[TBL] [Abstract][Full Text] [Related]
26. NLRP3 inflammasome inhibition attenuates subacute neurotoxicity induced by acrylamide in vitro and in vivo.
Sui X; Yang J; Zhang G; Yuan X; Li W; Long J; Luo Y; Li Y; Wang Y
Toxicology; 2020 Feb; 432():152392. PubMed ID: 32014472
[TBL] [Abstract][Full Text] [Related]
27. Pharmacological inhibition of the NLRP3 inflammasome as a potential target for cancer-induced bone pain.
Chen SP; Zhou YQ; Wang XM; Sun J; Cao F; HaiSam S; Ye DW; Tian YK
Pharmacol Res; 2019 Sep; 147():104339. PubMed ID: 31276771
[TBL] [Abstract][Full Text] [Related]
28. The NLRP3 inflammasome contributes to inflammation-induced morphological and metabolic alterations in skeletal muscle.
Eggelbusch M; Shi A; Broeksma BC; Vázquez-Cruz M; Soares MN; de Wit GMJ; Everts B; Jaspers RT; Wüst RCI
J Cachexia Sarcopenia Muscle; 2022 Dec; 13(6):3048-3061. PubMed ID: 35978267
[TBL] [Abstract][Full Text] [Related]
29. Endometrial inflammasome activation accompanies menstruation and may have implications for systemic inflammatory events of the menstrual cycle.
Azlan A; Salamonsen LA; Hutchison J; Evans J
Hum Reprod; 2020 Jun; 35(6):1363-1376. PubMed ID: 32488243
[TBL] [Abstract][Full Text] [Related]
30. Time-dependent dual effect of NLRP3 inflammasome in brain ischaemia.
Palomino-Antolin A; Narros-Fernández P; Farré-Alins V; Sevilla-Montero J; Decouty-Pérez C; Lopez-Rodriguez AB; Fernández N; Monge L; Casas AI; Calzada MJ; Egea J
Br J Pharmacol; 2022 Apr; 179(7):1395-1410. PubMed ID: 34773639
[TBL] [Abstract][Full Text] [Related]
31. Pharmacological inhibition of the NLRP3 inflammasome reduces blood pressure, renal damage, and dysfunction in salt-sensitive hypertension.
Krishnan SM; Ling YH; Huuskes BM; Ferens DM; Saini N; Chan CT; Diep H; Kett MM; Samuel CS; Kemp-Harper BK; Robertson AAB; Cooper MA; Peter K; Latz E; Mansell AS; Sobey CG; Drummond GR; Vinh A
Cardiovasc Res; 2019 Mar; 115(4):776-787. PubMed ID: 30357309
[TBL] [Abstract][Full Text] [Related]
32. Inflammasome Activation in Ankylosing Spondylitis Is Associated With Gut Dysbiosis.
Guggino G; Mauro D; Rizzo A; Alessandro R; Raimondo S; Bergot AS; Rahman MA; Ellis JJ; Milling S; Lories R; Elewaut D; Brown MA; Thomas R; Ciccia F
Arthritis Rheumatol; 2021 Jul; 73(7):1189-1199. PubMed ID: 33452867
[TBL] [Abstract][Full Text] [Related]
33. A selective inhibitor of the NLRP3 inflammasome as a potential therapeutic approach for neuroprotection in a transgenic mouse model of Huntington's disease.
Chen KP; Hua KF; Tsai FT; Lin TY; Cheng CY; Yang DI; Hsu HT; Ju TC
J Neuroinflammation; 2022 Feb; 19(1):56. PubMed ID: 35219323
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of NLRP3 Inflammasome Prevents LPS-Induced Inflammatory Hyperalgesia in Mice: Contribution of NF-κB, Caspase-1/11, ASC, NOX, and NOS Isoforms.
Dolunay A; Senol SP; Temiz-Resitoglu M; Guden DS; Sari AN; Sahan-Firat S; Tunctan B
Inflammation; 2017 Apr; 40(2):366-386. PubMed ID: 27924425
[TBL] [Abstract][Full Text] [Related]
35. Microglial NLRP3 inflammasome activation mediates IL-1β release and contributes to central sensitization in a recurrent nitroglycerin-induced migraine model.
He W; Long T; Pan Q; Zhang S; Zhang Y; Zhang D; Qin G; Chen L; Zhou J
J Neuroinflammation; 2019 Apr; 16(1):78. PubMed ID: 30971286
[TBL] [Abstract][Full Text] [Related]
36. The selective NLRP3 inflammasome inhibitor MCC950 alleviates cholestatic liver injury and fibrosis in mice.
Qu J; Yuan Z; Wang G; Wang X; Li K
Int Immunopharmacol; 2019 May; 70():147-155. PubMed ID: 30802677
[TBL] [Abstract][Full Text] [Related]
37. MCC950 attenuates inflammation-mediated damage in canines with Staphylococcus pseudintermedius keratitis by inhibiting the NLRP3 inflammasome.
Guo L; Wang Z; Li J; Cui L; Dong J; Meng X; Zhu G; Li J; Wang H
Int Immunopharmacol; 2022 Jul; 108():108857. PubMed ID: 35597123
[TBL] [Abstract][Full Text] [Related]
38. MCC950 in the treatment of NLRP3-mediated inflammatory diseases: Latest evidence and therapeutic outcomes.
Bakhshi S; Shamsi S
Int Immunopharmacol; 2022 May; 106():108595. PubMed ID: 35124417
[TBL] [Abstract][Full Text] [Related]
39. NLRP3 inflammasome activates interleukin-23/interleukin-17 axis during ischaemia-reperfusion injury in cerebral ischaemia in mice.
Wang H; Zhong D; Chen H; Jin J; Liu Q; Li G
Life Sci; 2019 Jun; 227():101-113. PubMed ID: 31002919
[TBL] [Abstract][Full Text] [Related]
40. Propionibacterium acnes induces intervertebral disc degeneration by promoting nucleus pulposus cell pyroptosis via NLRP3-dependent pathway.
He D; Zhou M; Bai Z; Wen Y; Shen J; Hu Z
Biochem Biophys Res Commun; 2020 Jun; 526(3):772-779. PubMed ID: 32265028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
